Details
Stereochemistry | RACEMIC |
Molecular Formula | C14H18F3NO.ClH |
Molecular Weight | 309.755 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CC(C)N1CCOC(C1)C2=CC(=CC=C2)C(F)(F)F
InChI
InChIKey=XYYSVSLSSDHEGA-UHFFFAOYSA-N
InChI=1S/C14H18F3NO.ClH/c1-10(2)18-6-7-19-13(9-18)11-4-3-5-12(8-11)14(15,16)17;/h3-5,8,10,13H,6-7,9H2,1-2H3;1H
Molecular Formula | C14H18F3NO |
Molecular Weight | 273.294 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Oxaflozane is non-tricyclic antidepressant with serotoninergic action. In animals, oxaflozane has anti-cataleptic and anti-aggressive action with weak potentiation of stereotypes provoked by amphetamine. Oxaflozane was developed by Solvay Pharma and marketed in France under tradename Conflictan. The drug was discontinued in 2004.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 20:16:40 GMT 2023
by
admin
on
Fri Dec 15 20:16:40 GMT 2023
|
Record UNII |
E10FW59D1I
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
247-854-2
Created by
admin on Fri Dec 15 20:16:40 GMT 2023 , Edited by admin on Fri Dec 15 20:16:40 GMT 2023
|
PRIMARY | |||
|
315281
Created by
admin on Fri Dec 15 20:16:40 GMT 2023 , Edited by admin on Fri Dec 15 20:16:40 GMT 2023
|
PRIMARY | |||
|
m861
Created by
admin on Fri Dec 15 20:16:40 GMT 2023 , Edited by admin on Fri Dec 15 20:16:40 GMT 2023
|
PRIMARY | Merck Index | ||
|
E10FW59D1I
Created by
admin on Fri Dec 15 20:16:40 GMT 2023 , Edited by admin on Fri Dec 15 20:16:40 GMT 2023
|
PRIMARY | |||
|
100000085504
Created by
admin on Fri Dec 15 20:16:40 GMT 2023 , Edited by admin on Fri Dec 15 20:16:40 GMT 2023
|
PRIMARY | |||
|
26629-86-7
Created by
admin on Fri Dec 15 20:16:40 GMT 2023 , Edited by admin on Fri Dec 15 20:16:40 GMT 2023
|
PRIMARY | |||
|
SUB03560MIG
Created by
admin on Fri Dec 15 20:16:40 GMT 2023 , Edited by admin on Fri Dec 15 20:16:40 GMT 2023
|
PRIMARY | |||
|
C005357
Created by
admin on Fri Dec 15 20:16:40 GMT 2023 , Edited by admin on Fri Dec 15 20:16:40 GMT 2023
|
PRIMARY | |||
|
21124624
Created by
admin on Fri Dec 15 20:16:40 GMT 2023 , Edited by admin on Fri Dec 15 20:16:40 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ENANTIOMER -> RACEMATE | |||
|
ENANTIOMER -> RACEMATE | |||
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |